Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hedner

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 20, 2002
The clinical profile of the angiotensin II receptor blocker eprosartanThomas Hedner
Blood Pressure|April 21, 2017
The Problem of Hypertension in the ElderlyThomas Hedner
Pain|July 1, 1991
Pain characterization in cancer patients and the analgetic response to epidural morphineHåkan Samuelsson, Thomas Hedner
Lakartidningen|January 6, 2005
[Reflections on COX, Vioxx and Relifex. Increased cardiovascular risk following selective COX-2 inhibition]Thomas Hedner, Arne Melander
Lakartidningen|August 3, 2012
[Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]Thomas Hedner, Lars Gatenbeck
Lakartidningen|March 5, 2013
[Swedish research needs Swedish innovation. The research and innovation strategy must strengthen Swedish competitiveness]Thomas Hedner, Olle Larkö
Blood Pressure|October 4, 2002
The Blood Pressure 10th Anniversary Research PrizeLennert Hansson, Thomas Hedner
Blood Pressure|November 17, 2004
Cardiovascular complications of COX2 selective inhibitors cause considerable concernThomas Hedner, Anders Himmelmann
Drug Discovery Today|March 8, 2016
Entrepreneurial patent management in pharmaceutical startupsMarcus Holgersson, Tai Phan, Thomas Hedner
Blood Pressure|January 14, 2003
Blood pressure measurement: a century of achievements and improvements in the year 2002Anders Himmelmann, Lennart Hansson, Thomas Hedner
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 20, 2002
The clinical profile of the angiotensin II receptor blocker eprosartanThomas Hedner
Blood Pressure|April 21, 2017
The Problem of Hypertension in the ElderlyThomas Hedner
Pain|July 1, 1991
Pain characterization in cancer patients and the analgetic response to epidural morphineHåkan Samuelsson, Thomas Hedner
Lakartidningen|January 6, 2005
[Reflections on COX, Vioxx and Relifex. Increased cardiovascular risk following selective COX-2 inhibition]Thomas Hedner, Arne Melander
Lakartidningen|August 3, 2012
[Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]Thomas Hedner, Lars Gatenbeck
Lakartidningen|March 5, 2013
[Swedish research needs Swedish innovation. The research and innovation strategy must strengthen Swedish competitiveness]Thomas Hedner, Olle Larkö
Blood Pressure|October 4, 2002
The Blood Pressure 10th Anniversary Research PrizeLennert Hansson, Thomas Hedner
Blood Pressure|November 17, 2004
Cardiovascular complications of COX2 selective inhibitors cause considerable concernThomas Hedner, Anders Himmelmann
Drug Discovery Today|March 8, 2016
Entrepreneurial patent management in pharmaceutical startupsMarcus Holgersson, Tai Phan, Thomas Hedner
Blood Pressure|January 14, 2003
Blood pressure measurement: a century of achievements and improvements in the year 2002Anders Himmelmann, Lennart Hansson, Thomas Hedner
Pageof 13